Analyzing networks of phenotypes in complex diseases: Methodology and applications in COPD

BMC Systems Biology

Volumn 8, Issue 1, 2014, Pages

  Chu, Jen hwa ^a   Hersh, Craig P ^a   Castaldi, Peter J ^a   Cho, Michael H ^a   Raby, Benjamin A ^a   Laird, Nan ^b   Bowler, Russell ^c   Rennard, Stephen ^d   Loscalzo, Joseph ^a   Quackenbush, John ^b,e   Silverman, Edwin K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

COPD; Genetic association analysis; Network medicine; Phenotypic networks

Indexed keywords

BIOLOGY; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETICS; HUMAN; PHENOTYPE; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84902915567     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-8-78     Document Type: Article

References (29)

1. Silverman EK. Exacerbations in chronic obstructive pulmonary disease do they contribute to disease progression?. Proc Am Thorac Soc 2007, 4(8):586-590.
2. Barabási A-L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Genet Rev 2011, 12:56-68.
3. Vidal M, Cusick ME, Barabási A-L. Interactome networks and human disease. Cell 2011, 144:986-998.
4. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
5. Djebbari A, Quackenbush J. Seeded bayesian networks: constructing genetic networks from microarray data. BMC Syst Biol 2008, 2(1):57.
6. Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L. The human disease network. Proc Natl Acad Sci 2007, 104(21):8685-8690.
7. Schäfer J, Strimmer K. An empirical Bayes approach to inferring large-scale gene association networks. Bioinformatics 2005, 21(6):754-764.
8. Chu J, Lazarus R, Carey VJ, Raby BA. Quantifying differential gene connectivity between disease states for objective identification of disease-relevant genes. BMC Syst Biol 2011, 5(89).
9. Schäfer J, Strimmer K. A shrinking approach to large-scale covariance matrix estimation and implications for functional genomics. Stat Appl Genet Mol Biol 2007, 4(32).
10. Hotelling H. New light on the correlation coefficient and its transforms. J R Stat Soc B 1953, 15:193-232.
11. Opgen-Rhein R, Strimmer K. From correlation to causation networks: a simple approximate learing algorithm and its application to high-dimensional plant gene expression data. BMC Syst Biol 2007, 1(37).
12. Senior RM, Silverman EK. Chronic obstructive pulmonary disease. ACP Medicine: Pulmonary 2011, 2-2. Hamilton: Decker Publishing, Nabel EG.
13. Hersh CP, Jacobson FL, Gill R, Silverman EK. Computed tomography phenotypes in severe, early-onset chronic obstructive pulmonary disease. COPD 2007, 4(4):331-337.
14. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010, 11(122).
15. Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Criner GJ, Kim V, Bowler RP, Hanania NA, Anzueto AR, Make BJ, Hokanson JE, Crapo JD, Silverman EK, Martinez FJ, Washko GR. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: Associated radiologic phenotypes. Radiology 2011, 216(1):274-282.
16. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010, 7(1):32-43.
17. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R. ECLIPSE investigators: Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2011, 31(4):869-873.
18. Fitch AM, Jones MB. Shortest path analysis using partial correlations for classifying gene functions from gene expression data. Bioinformatics 2009, 25(1):42-47.
19. Schroeder JD, McKenzie AS, Zach JA, Wilson CG, Curran-Everett D, Stinson DS, Newell J, Lynch DA. Relationships between airflow obstruction and quantitative ct measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. Am J Roentgenol 2013, 201(3):460-470.
20. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, Ruppert A, Lødrup Carlsen KC, Roses A, Anderson W, Rennard SI, Lomas DA, Silverman EK, Goldstein DB, . ICGN Investigators A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5(3):1000421. ICGN Investigators.
21. Wilk JB, Chen T, Gottlieb DJ, Walter RE, Nagle MW, Brandler BJ, Myers RH, Borecki IB, Silverman EK, Weiss ST, O'Connor GT. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009, 5(3):1000429.
22. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, Lange C, Won S, Murphy JR, Beaty TH, Regan EA, Make BJ, Hokanson JE, Crapo JD, Kong X, Anderson WH, Tal-Singer R, Lomas DA, Bakke P, Gulsvik A, Pillai SG, Silverman EK. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nature Genet 2010, 42(3):200-202.
23. Cho MH, McDonald M-LN, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, DeMeo DL, Sylvia JS, Ziniti J, Laird NM, Lange C, Litonjua AA, Sparrow D, Casaburi R, Barr RG, Regan EA, Make BJ, Hokanson JE, Lutz S, Dudenkov TM, Farzadegan H, Hetmanski JB, Tal-Singer R, Lomas DA, Bakke P, Gulsvik A, Crapo JD, Silverman EK, Beaty TH. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med 2014, [10.1016/S2213-2600(14)70002-5].
24. Rosa GJM, Valente BD, de los C, Wu X-L, Gianola D, Silva MA. Inferring causal phenotype networks using structural equation models. Genet Sel Evol 2011, 43(6).
25. Chen J, Lu P, Zuo X, Shi Q, Zhao H, Luo L, Yi J, Zheng C, Yang Y, Wang W. Clinical datamining of phenotypic network in angina pectoris of coronary heart disease. Evid base Compl Alternative Med 2012, 2012:546230.
26. Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med 2011, 183(9):1129-1137.
27. Davis DA, Chawla NV. Exploring and exploiting disease interactions from multi-relational gene and phenotype networks. PLoS ONE 2011, 6(7):22670.
28. Yao X, Hao H, Li Y, Li S. Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network. BMC Syst Biol 2011, 5(79).
29. Hidalgo CA, Blumm N, Barabási A-L, Christakis NA. A dynamic network approach for the study of human phenotypes. PLoS Comput Biol 2009, 5(4):1000353.